255 related articles for article (PubMed ID: 37537560)
1. Etiological relationship between lipid metabolism and endometrial carcinoma.
Li W; Xu Y; Zeng X; Tan J; Wang Y; Wu H; Li M; Yi C
Lipids Health Dis; 2023 Aug; 22(1):116. PubMed ID: 37537560
[TBL] [Abstract][Full Text] [Related]
2. Silibinin inhibits endometrial carcinoma via blocking pathways of STAT3 activation and SREBP1-mediated lipid accumulation.
Shi Z; Zhou Q; Gao S; Li W; Li X; Liu Z; Jin P; Jiang J
Life Sci; 2019 Jan; 217():70-80. PubMed ID: 30452972
[TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links.
Wang Y; Zeng X; Tan J; Xu Y; Yi C
Medicine (Baltimore); 2022 Aug; 101(34):e30299. PubMed ID: 36042597
[TBL] [Abstract][Full Text] [Related]
4. Beyond lipid-lowering: role of statins in endometrial cancer.
Hafizz AMHA; Zin RRM; Aziz NHA; Kampan NC; Shafiee MN
Mol Biol Rep; 2020 Oct; 47(10):8199-8207. PubMed ID: 32897522
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy.
Karadeniz Z; Aynacıoğlu AŞ; Bilir A; Tuna MY
Med Hypotheses; 2020 Jan; 134():109420. PubMed ID: 31634770
[TBL] [Abstract][Full Text] [Related]
6. The Regulatory Role of Lipid Metabolism in Endometrial Cancer.
Zhang S; Han X
J Oncol; 2022; 2022():6458877. PubMed ID: 36072980
[TBL] [Abstract][Full Text] [Related]
7. Targeting fibroblast growth factor pathways in endometrial cancer.
Winterhoff B; Konecny GE
Curr Probl Cancer; 2017; 41(1):37-47. PubMed ID: 28041631
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic and Lipidomic Profiling Identifies The Role of the RNA Editing Pathway in Endometrial Carcinogenesis.
Altadill T; Dowdy TM; Gill K; Reques A; Menon SS; Moiola CP; Lopez-Gil C; Coll E; Matias-Guiu X; Cabrera S; Garcia A; Reventos J; Byers SW; Gil-Moreno A; Cheema AK; Colas E
Sci Rep; 2017 Aug; 7(1):8803. PubMed ID: 28821813
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of squalene epoxidase linking with PI3K/AKT signaling pathway suppresses endometrial cancer.
Ma L; Huang W; Liang X; Bai G; Wang X; Jiang H; Xin Y; Hu L; Chen X; Liu C
Cancer Sci; 2023 Sep; 114(9):3595-3607. PubMed ID: 37438885
[TBL] [Abstract][Full Text] [Related]
10. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
Lange C; Machado Weber A; Schmidt R; Schroeder C; Strowitzki T; Germeyer A
PLoS One; 2021; 16(3):e0248103. PubMed ID: 33690729
[TBL] [Abstract][Full Text] [Related]
11. MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy.
Ran X; Yang J; Liu C; Zhou P; Xiao L; Zhang K
Int J Clin Exp Pathol; 2015; 8(6):6617-26. PubMed ID: 26261543
[TBL] [Abstract][Full Text] [Related]
12. Endometrial Carcinoma: Specific Targeted Pathways.
Eritja N; Yeramian A; Chen BJ; Llobet-Navas D; Ortega E; Colas E; Abal M; Dolcet X; Reventos J; Matias-Guiu X
Adv Exp Med Biol; 2017; 943():149-207. PubMed ID: 27910068
[TBL] [Abstract][Full Text] [Related]
13. MELK promotes Endometrial carcinoma progression via activating mTOR signaling pathway.
Xu Q; Ge Q; Zhou Y; Yang B; Yang Q; Jiang S; Jiang R; Ai Z; Zhang Z; Teng Y
EBioMedicine; 2020 Jan; 51():102609. PubMed ID: 31915116
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-381 inhibits cell proliferation and invasion in endometrial carcinoma by targeting the IGF-1R.
Tu C; Wang F; Wan J
Mol Med Rep; 2018 Mar; 17(3):4090-4098. PubMed ID: 29257334
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of genes involved in the insulin signalling pathway (IGF1, PTEN and IGFBP1) in the endometrium may link polycystic ovarian syndrome and endometrial cancer.
Shafiee MN; Seedhouse C; Mongan N; Chapman C; Deen S; Abu J; Atiomo W
Mol Cell Endocrinol; 2016 Mar; 424():94-101. PubMed ID: 26802879
[TBL] [Abstract][Full Text] [Related]
16. Fatostatin inhibits the development of endometrial carcinoma in endometrial carcinoma cells and a xenograft model by targeting lipid metabolism.
Yao L; Chen S; Li W
Arch Biochem Biophys; 2020 May; 684():108327. PubMed ID: 32142890
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer.
Roškar L; Roškar I; Rižner TL; Smrkolj Š
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053155
[TBL] [Abstract][Full Text] [Related]
18. Endometrial Cancer as a Metabolic Disease with Dysregulated PI3K Signaling: Shedding Light on Novel Therapeutic Strategies.
Kyo S; Nakayama K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842547
[TBL] [Abstract][Full Text] [Related]
19. LncRNA HOXB-AS3 binding to PTBP1 protein regulates lipid metabolism by targeting SREBP1 in endometrioid carcinoma.
Zhou Q; Kong D; Li W; Shi Z; Liu Y; Sun R; Ma X; Qiu C; Liu Z; Hou Y; Jiang J
Life Sci; 2023 May; 320():121512. PubMed ID: 36858312
[TBL] [Abstract][Full Text] [Related]
20. Targeting molecular pathways in endometrial cancer: a focus on the FGFR pathway.
Lee PS; Secord AA
Cancer Treat Rev; 2014 May; 40(4):507-12. PubMed ID: 24332498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
